U.S. Subcutaneous Drug Delivery Devices Market Size & Outlook
U.S. subcutaneous drug delivery devices market, 2018-2030 (US$M)
Related Markets
U.S. subcutaneous drug delivery devices market highlights
- The U.S. subcutaneous drug delivery devices market generated a revenue of USD 11,505.9 million in 2023 and is expected to reach USD 23,565.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
- In terms of segment, pen injectors was the largest revenue generating product in 2023.
- Wearable injectors is the most lucrative product segment registering the fastest growth during the forecast period.
Subcutaneous drug delivery devices market data book summary
| Market revenue in 2023 | USD 11,505.9 million |
| Market revenue in 2030 | USD 23,565.2 million |
| Growth rate | 10.8% (CAGR from 2023 to 2030) |
| Largest segment | Pen injectors |
| Fastest growing segment | Wearable injectors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free injectors |
| Key market players worldwide | Gerresheimer AG ADR, Medtronic PLC, Ypsomed Holding AG, Novo Nordisk A/S ADR, Insulet Corp, Becton Dickinson & Co, West Pharmaceutical Services Inc, PHARMAJET, Unilife Corporation |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.0% of the global subcutaneous drug delivery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. subcutaneous drug delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 4,947.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. subcutaneous drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to subcutaneous drug delivery devices market will help companies and investors design strategic landscapes.
Pen injectors was the largest segment with a revenue share of 36.59% in 2023. Horizon Databook has segmented the U.S. subcutaneous drug delivery devices market based on prefilled syringes, pen injectors, auto-injectors, wearable injectors, needle-free injectors covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. subcutaneous drug delivery devices market is significantly influenced by the high prevalence of diabetes and prediabetes, with an estimated 136 million adults affected in the U.S., as of November 2023, according to CDC.
This demographic presents a vast opportunity for subcutaneous drug delivery devices, especially for insulin administration. The CDC's report emphasizes the need for effective diabetes management tools, highlighting the market's potential for growth.
Reasons to subscribe to U.S. subcutaneous drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. subcutaneous drug delivery devices market databook
-
Our clientele includes a mix of subcutaneous drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. subcutaneous drug delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. subcutaneous drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. subcutaneous drug delivery devices market size, by product, 2018-2030 (US$M)
U.S. Subcutaneous Drug Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
